click below
click below
Normal Size Small Size show me how
basic drug therapy f
drug therapy final
Question | Answer |
---|---|
agonist | drugs that interact with a receptor to stimulate a predicable response |
agranulocytosis | abnormal condition of the blood causing severe reduction of the number of granulocytes. |
carinogenicity | effects of drugs or substances that cause the increase of cancer |
displacement | one drug takes the place of another drug increasing the activity of the 1st. |
leukocytosis | excess of white blood cells |
nephrotoxicity | drug or substance has destructive effect on kidney |
passive diffusion | movement from higher to lower across a membrane |
pharmacology | the study of drugs and their interactions in living organisms |
distribuiton | the transport of drug molecules through the body |
protein binding | the reaction of a drug with albumin that allows the albumin to release part of the drug dosage and store the other part. |
thrombocytopenia | abnormal hematologic condition which there are decreased # of platelets |
tolerence | increasing resistance to the usual effects of an established dosage of a drug as a result of continued use |
adverse reactions | an action that is different than the planned effect |
depression | decrease in activity of cells caused by the action of a drug |
idiosyncratic | abnormal or unusual action of a drug when it is 1st administered, particular to the individual |
prophylactic | an agent or measure used to prevent disease |
therapeutic | positive change or desired effect caused by a drug |
anaphylaxis | an extreme hypersensitivity to a drug and is an emergency situation |
generic name | the name of a drug that is related to the chemical or official name and is independent of the manufacturer |
serum albumin | protein in the blood |
infant absorption | weight is most significantover age. Topical absorption is faster than adult |
narcotic administration | (blank) |
Schedule 1 drug | high potential for abuse, illegal |
schedule 2 drug | high potential for abuse, may lead to severe dependence |
schedule 3 | may lead to moderate or low dependence |
schedule 4 | low potential for abuse |
category A | no risk to fetus in first trimester has been shown |
category B | no risk has been seen in animals, there is insufficient data regarding pregnant women |
Category C | adverse effects have been seen in animals but insufficient data in pregnant women |
category D | human fetal risk has been demonstrated |
Category X | human fetal risk is clearly documented |
interference | one drug inhibits the metabolism or exretion of another drug |
demulence | any of several oily substances used to soothe a body part or decrease inflamation |
onset | time it takes a drug to elicit a therapeutic response |
duration | time the drug concentration is sufficient to elicit a therapeutic response |
peak | time it takes a drug to reach its maximum therapeutic response |
FDA | food drug administration |
poly-pharmacy | the use of many different drugs in treating a patient who may have one or several health problems |
stat | give one time, immediately |
prn | give as necessary |
now | give now |
asap | as soon as possible |
supplemental therapy | gives the body a substance needed to maintain normal function |
incompatibility | 2 drugs that when used together cause deterioration of one drug or a drug interaction. |
antagonist | opposing actions of drugs |
biotransformation | metabolism |
chemical mediators | powerful substances liberated during the inflammatory process |
leukopenia | lack of white blood cells |
pallative | care of comfort |
pharmacodynamics | the way the drug works in the tissue at the cell level |
pharmacokinetics | absorption, distribution, metabolism, excretion |
absorption | process that occurs between the time a drug enters the body and the time it enters the blood stream |
excretion | the elimination of a drug from the body |
teratogenicity | result in structural defects in unborn fetus |
synergist | the combined effect of two drugs is greater than each drug taken alone. |
maintenance dose | dose needed to achieve therapuetic level |
untoward effects | (blank) |
potentiate | an effect that occurs when a drug increases or prolongs the action of another drug |
facilitated diffusion | drug molecules are combined with a carrier substance to move across membranes |
controlled substance | drugs regulated for distribution and catergorized by therapeutic usefulness and potential for abuse |
cumulative effects | when drugs are not excreted from the body as new drugs are absorbed |
half-life | the time required for the serum concentration of a drug to decrease by 50% |
brand name | same as trade name, has the registered trade mark. registered by the manufacturer |
trade name | the name designated and patented by the manufacturer |
nursing processs R/T drug admin. | record, report and monitor |
efficacy | effectiveness of a drug, drugs ability to produce a desired chemical change in the body |
admin schedules | (blank) |
negligence | conduct that falls below the established standard of care |
malpractice | professional misconduct and lack of skill in the performace of a duty or task |
maintenance therapy | (blank) |
dependence | a psychological or physilogical need for a drug |
percutaneous | topical, sublingual, inhale |
parenteral | IV (the fastest route) IM, SQ |
enteral | oral (slowest route) nasogastic-,j-tube |
single | administer at a certain time, only once |
hypersensitivity/allergic reaction | occurs having been previously exposed to a drug |